Montelucaste Para Crianças Com Idades Compreendidas Entre 6 Meses E 5 Anos De Idade Ratiopharm (Montelukast)

Montelukast, the active ingredient in Montelucaste Para Crianças Com Idades Compreendidas Entre 6 Meses E 5 Anos De Idade Ratiopharm, is a leukotriene receptor antagonist presented as an oral formulation for pediatric use. It is used to prevent asthma symptoms and manage allergic rhinitis in children aged six months to five years.

GNH USA supplies Montelucaste Para Crianças Com Idades Compreendidas Entre 6 Meses E 5 Anos De Idade Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Montelukast acts on the leukotriene pathway to control chronic respiratory and allergic conditions in children.

- Asthma: prevention of chronic asthma symptoms and reduction of exacerbations in children 6 months–5 years. - Allergic rhinitis: relief of nasal congestion, sneezing and itching associated with pediatric allergic rhinitis.

Montelukast is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Abdominal pain: occasional discomfort. - Cough: transient irritation. - Sore throat: mild irritation of the pharynx. - Fever: low‑grade temperature elevation. - Nausea: occasional upset stomach.

Serious or Rare Side Effects: - Allergic reactions: rash, angioedema, or anaphylaxis. - Neuropsychiatric events: agitation, depression, or suicidal thoughts. - Liver enzyme elevation: signs of hepatic dysfunction. - Neutropenia: reduced white‑blood‑cell count. - Severe hypersensitivity: bronchospasm or swelling of the face and throat.

Before initiating therapy, consider the following safety measures.

- Neuropsychiatric monitoring: observe for mood changes, agitation, or depression. - Hepatic function: assess baseline liver enzymes in patients with liver disease. - Severe asthma caution: not a rescue medication; ensure appropriate rescue inhaler is available. - Hypersensitivity: avoid in patients with known allergy to montelukast or excipients. - Store at room temperature: keep in the original container, protect from moisture and heat.

Montelukast may interact with other medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Rifampin: induces metabolism, reducing montelukast efficacy. - Ketoconazole: inhibits metabolism, potentially increasing drug levels. - Phenobarbital: induces metabolism, lowering therapeutic effect.

Moderate Interactions (Monitor Closely): - Beta‑agonists: additive bronchodilation may enhance respiratory relief. - NSAIDs: may increase risk of cutaneous reactions. - Warfarin: monitor INR as montelukast can affect anticoagulation control.